Participants at the National Consultation on Regulation of Drug Trials, organized by Sama, Locost, CSER, AIPSN and Daf-K, in New Delhi on 26-27 September, 2011, expressed their deep concern about the unregulated proliferation of ill-regulated clinical trials in India following the liberalisation of norms for conduct of such trials in 2005.